Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-007085
Filing Date
2024-10-17
Accepted
2024-10-17 16:22:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3516
  Complete submission text file 0001959173-24-007085.txt   5098
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Subject) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39062 | Film No.: 241377849
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KORRO BIO, INC. ONE KENDALL SQUARE, BUILDING 600-700 CAMBRIDGE MA 02139
Business Address
Agarwal Vineet (Reporting) CIK: 0001997973 (see all company filings)

Type: 144